Personal profile
Fingerprint
Dive into the research topics where Paul Crowe is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
-
Restoration of adipose function in obese, glucose-tolerant men following pioglitazone treatment is associated with CCAAT enhancer-binding protein β upregulation
McGinty, A., Powell, L., Crowe, P., Kankara, C., McPeake, J., McCance, D., Young, I. & Trimble, E., Aug 2012, In: Clinical Science. 123, 3, p. 135–146 12 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile12 Link opens in a new tab Citations (Scopus)886 Downloads (Pure) -
The Yin and Yang of vitamin D receptor (VDR) signaling in neoplastic progression: Operational networks and tissue-specific growth control
Campbell, F. C., Xu, H., El-Tanani, M., Crowe, P. & Bingham, V., 01 Jan 2010, In: Biochemical Pharmacology. 79, 1, p. 1-9 9 p.Research output: Contribution to journal › Article › peer-review
99 Link opens in a new tab Citations (Scopus) -
Synthesis of A83586C analogs with potent anticancer and beta-catenin/ TCF4/osteopontin inhibitory effects and insights into how A83586C modulates E2Fs and pRb.
Hale, K. J., Manaviazar, S., Lazarides, L., George, J., Walters, M. A., Cai, J., Delisser, V. M., Bhatia, G. S., Peak, S. A., Dalby, S. M., Lefranc, A., Chen, Y. P., Wood, A. W., Crowe, P., Erwin, P. & El-Tanani, M., 05 Feb 2009, In: Organic Letters. 11, 3, p. 737-740 4 p.Research output: Contribution to journal › Article › peer-review
12 Link opens in a new tab Citations (Scopus) -
Agelastatin A: a novel inhibitor of osteopontin-mediated adhesion, invasion, and colony formation
Mason, C. K., McFarlane, S., Johnston, P. G., Crowe, P., Erwin, P. J., Domostoj, M. M., Campbell, F. C., Manaviazar, S., Hale, K. J. & El-Tanani, M., Mar 2008, In: Molecular Cancer Therapeutics. 7, 3, p. 548-558 11 p.Research output: Contribution to journal › Article › peer-review
79 Link opens in a new tab Citations (Scopus) -
RAN GTPase is an effector of the invasive/metastatic phenotype induced by osteopontin
Kurisetty, V. V., Johnston, P. G., Johnston, N., Erwin, P., Crowe, P., Fernig, D. G., Campbell, F. C., Anderson, I. P., Rudland, P. S. & El-Tanani, M. K., 04 Dec 2008, In: Oncogene. 27, 57, p. 7139-7149 11 p.Research output: Contribution to journal › Article › peer-review
73 Link opens in a new tab Citations (Scopus)